Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones  by Evan, Andrew E. et al.
Histopathology and surgical anatomy of patients
with primary hyperparathyroidism and calcium
phosphate stones
Andrew E. Evan1, James E. Lingeman2, Fredric L. Coe3, Nicole L. Miller4, Sharon B. Bledsoe1,
Andre J. Sommer5, James C. Williams1, Youzhi Shao1 and Elaine M. Worcester3
1Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA; 2International Kidney
Stone Institute, Methodist Clarian Hospital, Indianapolis, Indiana, USA; 3Department of Medicine, University of Chicago, Chicago, Illinois,
USA; 4Department of Urology, Vanderbilt University, Nashville, Tennessee, USA and 5Department of Chemistry and Biochemistry,
Miami University, Oxford, Ohio, USA
Using a combination of intra-operative digital photography
and micro-biopsy we measured renal cortical and papillary
changes in five patients with primary hyperparathyroidism
and abundant calcium phosphate kidney stones. Major tissue
changes were variable papillary flattening and retraction,
dilation of the ducts of Bellini, and plugging with apatite
deposits of the inner medullary collecting ducts and ducts of
Bellini. Some of the papillae in two of the patients contained
plentiful large interstitial deposits of Randall’s plaque and
where the deposits were most plentiful we found overgrowth
of the attached stones. Hence, this disease combines features
previously described in brushite stone formers – dilation,
plugging of ducts and papillary deformity – with the
interstitial plaque and stone overgrowth characteristic of
routine idiopathic calcium oxalate stone formers, suggesting
that these two patterns can coexist in a single patient.
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Using a combination of intra-operative digital photography
and micro-biopsy, we have described gross and histopatho-
logical renal papillary and cortical changes in patients with
brushite,1 apatite stones, and distal renal tubular acidosis
(dRTA);2 and patients with calcium oxalate (CaOx) stones
from obesity bypass procedures,3 cystinuria,4 and idiopathic
CaOx stones (ICSF).3,5 In all but ICSF, we found (a) a
mixture of inner medullary collecting duct (IMCD) and duct
of Bellini (BD) plugging with apatite or, in the case of
cystinuria, IMCD apatite and BD cystine crystals; (b) variable
papillary flattening and atrophy; (c) interstitial fibrosis; and
(d) epithelial cell loss. In ICSF, by contrast, we found only
interstitial apatite deposits, the so-called Randall’s plaque6
with otherwise normal renal tissue. Of crucial importance,
stones appear to grow on papillary surfaces of ICSF at sites of
sub-urothelial plaque,5,6 whereas such overgrowth was not
found by us in any of the other aforementioned conditions.
Primary hyperparathyroidism (HPT) with stones spans a
spectrum from CaOx to calcium phosphate (CaP) stones;7,8
we would expect patients with HPT who form CaP stones to
have a surgical anatomy and renal histopathology similar to
those with brushite and apatite stone. However, to date this
prediction has not been tested. We report here the surprising
fact that among five patients with HPT and predominantly
CaP stones, we found both IMCD crystal plugging with
associated papillary injury, as well as abundant plaque with
attached stones. This is the first disease instance thus far in
which attached stones on plaque coexists with IMCD
plugging.
RESULTS
Clinical information
All but one patient was female, and had formed multiple
stones (Table 1). The stones from these patients that were
available for analysis were predominantly CaP; however, for
patient 1 we had only one stone that was analyzed as
predominantly CaOx. Parathyroidectomy was performed on
the day of, or within a few weeks after, percutaneous
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nephrolithotomy at which the renal biopsies reported here
were obtained. Hypercalcemia had been present for months
to years (Table 1), was of moderate degree (Table 2), and was
accompanied by elevated serum PTH levels. Pre-parathyr-
oidectomy 24-h urine studies were available in only two cases
(Table 2) and showed the expected hypercalciuria. A
parathyroid adenoma was found at surgery in all five patients
and successfully removed. In four cases we were able to
obtain postoperative serum calcium values (Table 2). Post-
parathyroidectomy urine calcium values were obtained from
all five patients and were normal, as were supersaturations
with respect to CaOx and CaP. Urine pH, a principle
determinant of CaP supersaturation, was not alkaline except
in patients 2 and 3 (Table 2); the peak of the pH value in
patient 3 indicates probable contamination with a urea-
splitting organism, which was confirmed by high ammonia
(53 mEq/day), and low magnesium (1.5 mg/day) and phos-
phate (0.114 g/day) levels. Notably, serum creatinine values
were slightly elevated and estimated glomerular filtration
rates reduced.
Table 1 presents the total number of stones found in each
patient and the net percentage of CaOx, hydroxyapatite/
brushite (HA/BR), and struvite for all analyzed stones. A
further breakdown of the number of stones analyzed per
patient and the composition of each stone is presented here.
Patient 1 had four stones analyzed with the following mineral
compositions: 42% HA and 58% CaOx; 73% HA and 27%
CaOx; 18% HA and 82% CaOx; 1% HA and 99% CaOx.
Patient 2 had two stones analyzed with the following mineral
compositions: 100% BR; 100% BR. Patient 3 had five stone
analyzed with the following mineral compositions: 32% HA
and 68% CaOx; 20% BR, 30% HA and 50% CaOx; 60% HA
and 40% CaOx; 100% BR; 50% HA and 50% CaOx. Patient 4
had two stones analyzed with the following mineral
compositions: 87% HA and 13% CaOx; 100% BR. Patient
5 had four stones analyzed with the following mineral
compositions: 90% HA and 10 CaOx; 45% HA and 55%
struvite; 37% HA and 63% CaOx; 89% HA and 11% CaOx.
Renal surgical pathology
Patient one displayed the least amount of papillary pathology
(Figure 1a), consisting of scattered white Randall’s plaque
in amounts similar to those found in normal people, that is
less than 1%.9 Even so, two papillae of this same patient
(Figure 1b) showed marked retraction, and markedly dilated
BD with protruding crystal plugs. All the papillae of patients
2 and 3 (Figures 2 and 3) showed the advanced changes,
retraction, BD dilation and plugging, that were seen in only
some papillae of patient 1. In addition, these two patients had
yellow plaque, the known gross morphological appearance of
Table 1 | Clinical characteristics of biopsied patients
Case Sex
Age of
first stone Stones ESWL PNL
Total
Procedures
Age at
biopsy
Age at
PTX
Duration of known
m serum Ca
Stone composition (%)
CaOx HA/BR Struvite
1 F 48 4/2 0 2/1 2/1 49 49 43.5 years 67 33/0 0
2 M 52 5/? 1/? 2/1 5/? 53 53 o12 months 0 0/100 0
3a F 29 11/7 0 3/1 13/5 34 34 5 years 28 34/38 0
4 F 30 3/2 1/1 1/1 4/2 37 37 2 years 7 43/50 0
5 F 33 3/1 0 1/1 3/1 34 34 3 months 21 65/0 14
BR, brushite; CaOx, calcium oxalate; ESWL, extra-corporeal shock wave lithotripsy before biopsy (total/biopsied kidney); HA, hydroxyapatite; PNL, percutaneous
nephrolithotomy before biopsy (total/biopsied kidney); Procedures, ureteroscopy, laser lithotripsy, nephrectomy, ESWL, PNL (total/biopsied kidney); PTX, parathyroidectomy;
Stones, total stones/stones from biopsied kidney; Stone composition, the net % including all analyzed stones.
aThis case had nephrectomy 1.5 years before biopsy, for non-function.
Table 2 | Selected laboratory data for biopsied patients
Case
Collection
period
Serum 24-h urine
Calcium
(mg per 100 ml)
PTH
(pg/ml)
Creat
(mg per 100 ml)
EGFR
(ml/min/1.73 m2) pH
Volume
(l day1)
Ca/Creat
(mg/g) SSCaOx SSCaP
1 Pre-PTX 11.0 172 1.1 56 ND ND ND ND ND
Post-PTX 9.3 76 1.2 51 5.58 1.32 107 4.4 0.14
2 Pre-PTX 12.2 233 0.8 107 6.90 2.41 174 7.5 2.4
Post-PTX 9.8 ND 1 83 6.89 2.12 118 5.7 2.1
3 Pre-PTX 11.2 149 1.2 55 ND ND ND ND ND
Post-PTX ND ND ND ND 8.54 0.94 11 1.2 0.1
4 Pre-PTX 10.8 188 0.9 75 5.65 1.92 261 11.9 1.1
Post-PTX 9.4 25 ND ND 5.97 1.28 75 7.1 0.8
5 Pre-PTX 11.3 143 1.5 42 ND ND ND ND ND
Post-PTX 8.1 ND 1.7 37 5.93 1.53 88 5.4 0.6
Ca/Creat, ratio of urine calcium to creatinine concentrations from 24 h collections, normal value is up to 140 mg/g; Creat, creatinine; eGFR, MDRD-calculated glomerular
filtration rate; post-PTX, post-parathyroidectomy; pre-PTX, pre-parathyroidectomy; PTH, parathyroid hormone; SS, supersaturation.
Serum and urine were not collected on the same days.
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IMCD apatite plugging.1 (Figures 2a and d and 3a and b).
Large amounts of white (Randall’s) plaque were also observed
(Figure 2b and c), as were attached stones in some areas of
white plaque (Figures 2a and c; 3a and b). Attached stones
were on the same papillae in which BD were plugged with
crystals (Figure 2a and c). Figure 3 shows an attached stone
on a papilla obtained from patient 3 prior to removal (Figure
3a); during removal, exposing a region of white plaque deep
within the site of stone attachment (Figure 3b); after removal
(Figure 3c); and a micro-computed tomography (mCT)
image of the same stone (Figure 3d). mCT analysis reveals the
mineral composition of the stone to be mixed, the whitish
areas being apatite and the gray areas CaOx dihydrate.
Patients 5 and 4 displayed the most advanced changes
(Figure 4). Papillae were flattened with numerous dilated BD
(Figure 4a and b), occasionally with crystalline plugs (arrow).
The visual impression that larger amounts of white plaque
were present on the papillae of patients 2 and 3 than on the
papillae of the other three patients was confirmed by digital
imaging. The percent of papillary surface covered by white
plaque in patients 2 and 3 exceeded that of the other three
patients by over 10-fold (Table 3).
Histopathological findings
Patient 1, who had a predominantly CaOx stone admixed
with 33% apatite, had a few, very large IMCD plugs (Figure
5a and b) with little plaque. Patient 3, who had brushite
and apatite stones, showed presence of large amount of
IMCD deposit on high-resolution CT and histopathology
(Figure 5c and d) along with abundant plaque. Patient 2, who
a
c
b
d
Figure 2 | Coexistence of attached stones and BD plugging
on the same papillae (patient 2). (a) Areas of yellow plaque
(IMCD crystal deposit, double arrowheads) and white interstitial
(Randall’s) plaque (single arrowhead) are found on one papilla.
One dilated BD has a crystalline plug (arrow) protruding from its
opening. A stone attached at an area of white plaque (within the
white box) is magnified in the inset at the upper right; the stone is
outlined within the inset by a black dotted overlay and the plaque
border is indicated with an arrow. (b) Large areas of white plaque
(single arrowhead) are evident on another papilla of this patient.
(c) On another papilla a stone (asterisk) is attached to the papilla
near an area of white plaque (single arrowhead). (d) On yet
another papilla a dilated BD with plugging (arrow) is near the
yellow plaque.
a b
Figure 1 | Range of papillary pathology in one patient
(patient 1). Most papillae were normal appearing (a) with small
regions of Randall’s plaque. Note the presence of biopsy forceps
at upper right. Two papillae contained markedly dilated BD
with crystalline plugging (b, arrow) and were retracted.
a b
c d
Figure 3 | Attached stone prior to, during, and after removal
(patient 3). (a) An attached stone (asterisk) is near areas of yellow
(double arrowhead) and white (single arrowhead) plaque.
(b) The stone in panel (a) is being removed by a basket during
percutaneous nephrolithotomy (asterisk); it was attached to an
area of white plaque (single arrowhead) deep beneath the stone
surface. This stone was also overlying a dilated BD (double arrows)
and is adjacent to a large crystalline plug (small arrows)
protruding from another dilated BD. (c) Light-microscopy image
of the stone (2 mm) in panel (b), after removal. Many large CaOx
dihydrate crystals (arrows) cover the urinary surface of the stone.
(d) mCT analysis of the same stone reveals a mixture of apatite
(white regions) and CaOx dihydrate (gray regions).
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also had brushite-containing stones, showed presence of a
similar amount of IMCD plugging and abundant plaque
(Figure 5e and f) as in patient 3; this patient, as noted, along
with patient 2, had stones attached to plaque (Figure 2a and
c). When found, by high-resolution CT and light microscopy,
patients 4 and 5 (not illustrated) to have a moderate amount
of BD plugging and dilation, but lacking abundant white
plaque and attached stones.
Pathological changes were extreme in some areas
(Figure 6a). Plugging of IMCD and BD with mineral led to
loss of cells and interstitial fibrosis in patient 3. Very heavy
deposits of Randall’s plaque were observed in patient 2
(Figure 6b, Table 3), with the expected preservation of
interstitial integrity. In patient 1 (Figure 6c), a single massive
intra-tubular plug (center of panel), visualized by high-
resolution CT in the lower left quadrant of the panel, led
to total loss of epithelial cells. The mineral phase reaches to
the surface of the basement membrane (lower right quadrant
of panel). A ring of fibroblasts surrounds the plugged duct.
The number of IMCD and BD deposits per biopsy differed
widely among our patients (Table 3). Three patients had
mineral deposits (patients 1, 4, and 5) extending from the
inner medulla through outer medulla to the cortex (Table 3).
In the outer medulla of patient 5 (Figure 7a), deposits are in
the outer medullary collecting ducts and extend into the
cortical collecting ducts (Figure 7b). The same changes in
patients 1 and 4 are not illustrated.
We determined the composition of intratubular deposits
in all five papillary and three cortical and outer medullary
sections using micro-Fourier transform infrared spectro-
meter; in every case, deposits were biological apatite
(Figure 8). In the two cases (patients 2 and 3) with abundant
interstitial plaque and attached stones, the mineral phase of
the plaque was biological apatite (Figure 8).
a b
Figure 4 | Severe papillary changes. Patient 5 (a) and patient 4
(b). The most severe changes consisted of papillary retraction and
flattening associated with numerous dilated BD (double arrows),
some with crystalline plugs (arrow); white plaque is absent.
Table 3 | Summary of pathological changes
Patient Papillary deformity (%) White plaque (%) Yellow plaque Attached stones IMCD/BD deposits Cortical deposits
1 o50 0.28 Some No 2±1 Yes
2 450 15.9 Some Yes 25±2 No
3 450 2.8 Some Yes 24±3 No
4 450 0.15 Some No 10±1 Yes
5 450 0.17 Some No 6±1 Yes
BD, duct of Bellini; IMCD, inner medullary collecting duct; IMCD/BD deposits, number of individual intra-luminal deposits per square millimeter of tissue, ±s.e.m.
Percent papillary deformity refers to the fraction of papillae visualized at the time of surgery with deformity; white plaque is expressed as percent of papillary surface covered
by white plaque; IMCD, previously published value for mean plaque coverage measured in four patients with no stone was 0.5%.9
a b
c d
e f
Figure 5 | Relative densities of IMCD deposits and interstitial
plaque. mCT imaging (a, c, e) and histopathology (b, d, f).
(a) Patient 1 had a few huge deposits (arrows) in IMCD by mCT
analysis. (b) One of the large deposits (single arrow) in patient 1 is
associated with loss of epithelium (decalcified light microscopic
section, double arrow); Randall’s plaque is not present. In patient
3 (c, d) and patient 2 (e, f), many IMCD deposits (arrows) are
associated with Randall’s plaque (arrowheads). Patients 4 and 5
had a moderate amount of IMCD deposits (not shown). Original
magnification  30 (b);  150 (d, f). Panels (d) and (f) are Yasue
staining images; panel (b) is an image of toluidine blue staining.
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DISCUSSION
All five of our patients exhibited the changes that were seen in
patients with brushite stone, that is, IMCD and BD plugging
with apatite crystals and loss of epithelial cell integrity, peri-
tubular interstitial inflammation and fibrosis about the
affected tubules; and papillary retraction and dilation of
BD and their openings.1 However, there are some differences.
Only in patient 1 did we observe the extreme of BD dilation
found regularly in brushite disease. Patients 2 and 3 had a
larger fraction of IMCD involved than among the those with
brushite stone that we have reported previously.1 In contrast,
our patients with dRTA had a very high fraction of IMCD
involved with crystal plugging,2 and somewhat less dramatic
tubule dilation than that in patients with brushite stone. So
one might say these five HPT patients share some traits of
both brushite disease and dRTA. Likewise, patients with
brushite stone had a very wide range of papillary involvement
within individual patients, ranging from retraction and
scarring to virtually normal, where in dRTA almost all
papillae are quite abnormal; our HPT patients are more like
those with brushite stone in having a wide range of changes.
On the basis of the above distinctions, the findings from five
HPT patients are similar to those from brushite disease and
dRTA patients, but more closely resemble brushite disease
than dRTA.
As patient 1 had only a net 33% of apatite in the stones
that we had analyzed, she could have been classified clinically
as having a CaOx stone. This finding from this one patient
suggests that in HPT, unlike ICSF, CaOx stones may well be
associated with the histopathology observed usually in
patients with CaP stone. This conjecture cannot be tested
until we biopsy more CaOx stone-containing patients with
a b
c
Figure 6 | Higher magnification reveals degree of cell loss and
interstitial fibrosis. (a) Massive IMCD plugging (arrows) is
associated with epithelial cell loss and severe fibrosis (patient 3).
(b) Areas of abundant interstitial plaque (patient 2, arrowheads)
were not associated with cell loss or interstitial fibrosis. (c) A large
deposit in patient 1 (mCT in lower left inset) lies within an IMCD
lumen (transmission electron microscopy, arrow); tubule cells
are absent and crystals are apposed directly to the basement
membrane (double arrow, detailed in lower right inset).
Surrounding interstitium is fibrotic (arrowheads). Original
magnification  500 (a, b);  1600 (c); and  4800
(right lower inset).
a b
Figure 7 | Mineral extends into the outer medulla and cortex
in patients 1, 4, and 5. Yasue-positive deposits were found in
outer medullary collecting ducts (a, arrows) and in the cortical
collecting ducts (b, arrow) of patient 5; the same changes in
patients 1 and 4 are not illustrated. Original magnification
 300 (a) and  200 (b).
Calcium oxalate
Hydroxyapatite
Intraluminal crystals
Interstitial crystals
Tissue with embedding media
4000 3000 2000 1500 1000 580
Wavenumbers (cm–1)
Figure 8 | Micro-Fourier-transform infrared spectrometer
analysis of intra-luminal deposits and interstitial plaque from
patient 3. Intra-luminal and interstitial crystals show a spectral
band matching that of the hydroxyapatite standard, but no bands
of the CaOx standard. Tissue with the embedding medium,
a control, displays bands in common with neither standard.
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HPT. One might mention in this regard that patients with
CaOx stone who have enteric hyperoxaluria have thus far also
showed presence of IMCD plugging with apatite, and are the
only other instances of the presence CaOx stones with any
crystals in their epithelial cell compartments.3
Unlike all four prior contrast groups with IMCD crystal
plugging, patients with brushite stone, enteric hyperoxaluria
with CaOx stones, dRTA, and cystinuria, these HPT patients
can have some of their stones attached to Randall’s plaque
(patients 2 and 3). That they can have abundant plaque is not
surprising in that hypercalciuria is well known in HPT10 and
a main pathophysiological correlate of plaque abundance.9
Patient 2 was in fact hypercalciuric (Table 2), and plaque
abundance was highest in patients 2 and 3 who had attached
stones. For reasons yet to be uncovered, HPT can produce
both pathologies: intratubular plugging and stone over-
growth on plaque, whereas no other disease yet described has
them in combination. We could speculate that urine pH and
volume, the other two factors controlling plaque abundance,9
permit plaque in HPT and not in the other conditions
involving IMCD plugging; this study cannot discuss this
matter further due to lack of sufficient pre-parathyroidect-
omy urine studies.
Our published reports have thus far included 10 patients
with brushite and 5 with dRTA stone.1,2 In our publications,
we did not chose to quantify whether stones were or were not
attached, although this was fully documented at the time of
our intraoperative observations. Among 82 fully studied
papillae from the 10 patients with brushite stone, we found
22 stones excluding the index stones that led to the surgery.
Of these, none were attached to plaque, but were rather sub-
urothelial or attached to plugs of crystal growing out of the
mouths of dilated BD. No stones were found attached to the
papillae of our 5 dRTA patients, our 5 patients with cystine
stone, 4 or our 4 patients with obesity bypass stone,3 all of
whom manifested IMCD apatite plugging. We offer these
observations to put the present results in as quantitative a
perspective as possible at this time.
Why IMCD plugging occurs in our HPT patients is an
unsettled matter. In patients with brushite stone, hypercal-
ciuria is more marked and urine pH is higher than in patients
CaOx stone;11 so supersaturation CaP is increased markedly
and would be expected to foster CaP crystallizations in urine
and IMCD and BD. The same is true for dRTA. We presume
that both factors (high urine pH and calcium) were present
in these HPT patients, but did not have the opportunity to
study them before curative surgery. Postoperative recordings
need not reflect those when HPT was present. More studies of
HPT are clearly needed.
We have found virtually no prior information about renal
tissue changes in primary HPT in patients who have stones;
PubMed searches in fact revealed only three publications on
the subject, and only when we relaxed the demand for stone
formation. All the three publications describe patients with
extreme hypercalcemia.12–14 Changes included calcifications
in glomeruli, mitochondria, and numerous tubular segments.
Serum calcium values ranged from 16 to 22 mg per 100 ml,
far exceeding those of our patients.
MATERIALS AND METHODS
Patients
We studied five patients with primary HPT stone who required
percutaneous nephrolithotomy at this institution (International
Kidney Stone Institute, Methodist Clarian Hospital, Indianapolis,
IN, USA) during the past 5 years (Table 1) and who consented to
participate in the study. Patients were not selected. Clinical history
was obtained along with reviews of old records to obtain stone
analysis and the type and number of stone procedures (Table 1).
Clinical laboratory studies
Two 24-h urine samples were collected while patients were on their
free-choice diet and were not on medications. In the urine we
measured volume, pH, level of calcium, oxalate, citrate, phosphate,
uric acid, sodium, potassium, magnesium, sulfate, and ammonia,
and calculated supersaturation with respect to CaOx, BR, and uric
acid using methods detailed elsewhere.11 Routine clinical blood
measurements were made on blood samples obtained for clinical
purposes.
Biopsy protocol and plaque area determination
During percutaneous nephrolithotomy, all papillae were digitally
imaged as described elsewhere.9 Biopsies were taken from one upper
pole, inter-polar, and lower pole papillum, and from the cortex.
Using intraoperative recordings,1 total surface area of each papilla
was measured, and one of us outlined the areas of white (Randall’s)
plaque as well as the entire papilla on one set of prints. The white
plaque and total papillary areas were converted to numbers of pixels,
yielding the ratio of plaque to total papillary pixels, or percent
coverage with plaque. No biopsy site inspected intraoperatively
displayed significant hemorrhage and no postoperative complica-
tions related to the biopsy procedures occurred in any patient. The
study was approved by the Institutional Review Board Committee
for Clarian Health Partners (no. 98-073).
Tissue analysis
General. Fifteen papillary and five cortical biopsies were
studied using light and transmission electron microscopy. All
biopsy (cortical and papillary) specimens were immersed in 5%
paraformaldehyde in 0.1 mol/l phosphate buffer (pH 7.4).
Light microscopy. Papillary and cortical biopsies were dehy-
drated through a series of graded ethanol concentrations to 100%
ethanol prior to being embedded in a 50/50 mixture of Paraplast
Xtra (Fisher Scientific, Itasca, IL, USA) and Peel-away Micro-Cut
(Polysciences Inc., Warrington, PA, USA). Serial sections were cut at
4 mm and stained by Yasue metal substitution method for calcium
histochemistry,3 and hematoxylin and eosin for routine histological
examination. An additional set of serial sections was cut at 7 mm for
infrared analysis.
Infrared. Reflectance–absorption spectra were collected with a
Perkin-Elmer Spotlight 400 infrared imaging microscope interfaced
to a Perkin-Elmer Spectrum One Fourier transform infrared
spectrometer. The system uses a 100 100 mm, liquid nitrogen-
cooled, mercury cadmium telluride (HgCdTe) detector. Samples
were analyzed using an aperture size suitable for the size of the
sample being studied (for example, 50–20 mm in diameter). Each
spectrum collected represents the average of 64 or 128 individual
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scans having a spectral resolution of 4 cm1. A clean area on the
low-E slide was employed to collect the background spectrum.
Attenuated total internal reflection spectra were collected with a
Perkin-Elmer Spotlight 400 infrared imaging microscope interfaced
to a Perkin-Elmer Spectrum One Fourier transform infrared
spectrometer. The system uses a 100 100mm, liquid nitrogen-
cooled, mercury cadmium telluride (HgCdTe) detector. The
standard germanium internal reflection element was employed in
conjunction with an aperture of 100 100 mm or 50 50 mm. Since
attenuated total internal reflection measurement is essentially an
immersion measurement, the sampled area using these apertures is
25 25 mm or 12.5 12.5 mm. Each spectrum collected represents
the average of 64 or 128 individual scans having a spectral resolution
of 4 cm1. A clean potassium chloride surface was used to collect the
background spectrum.
Transmission electron microscopy. The 5-mm biopsy speci-
mens of the renal papilla were divided into 1-mm blocks and
routinely processed for transmission electron microscopy before
being embedded.3 All thin sections were examined with an FEI G2
Tecnai 12 BioTwin transmission electron microscope (FEI, Hills-
boro, OR, USA), equipped with an AMT Corp., XR-60 Digital CCD
system.
lCT. All papillary biopsies underwent mCT analysis with the
SkyScan-1072 (Vluchtenburgstraat 3, B-2630 Aartselaar, Belgium)
high-resolution desktop mCT system allowing nondestructive
mapping of the location and size of the crystalline deposits within
a biopsy specimen. This mCT system can generate a tissue window so
that both the mineral deposit and tissue organization are seen at the
same time. For this protocol, biopsies are quickly dipped in a 1:10
dilution of Hypaque (50%; Nycomed Inc., Princeton, NJ, USA)/
phosphate-buffered saline, and then coated with a thin layer of
paraffin and mounted in the center of a small chuck which is then
locked into place in the machine. The sample was positioned in the
center of the beam and the system configuration was set at 35 kV,
209mA, 1801 rotation, with flat-field correction. Images were
recorded to CDs and reconstructed with Cone-Reconstruction
software by SkyScan. These images were then reconstructed into
three-dimensional images with SkyScan’s CTAnþCTVol software.
These images allowed us to properly orient each biopsy for future
light-microscopy analysis. Three separate scans from each patient
were used to determine the number of sites of intraluminal deposits
per square millimeter, except for patient 5 for whom paraffin
sections were used.
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